Short answer: no, not anymore. Sermorelin was FDA-approved once, decades ago, under a brand name most people have never heard of. That approval still exists on paper as a historical record, but the approved product itself is gone from the market. What is sold today under the name “sermorelin” is compounded — legal in most cases, but categorically not the same thing as FDA-approved. The difference between “legal” and “approved” is exactly where most of the confusion about this drug comes from. For what the compound actually does mechanistically, separate from its regulatory status, see what is sermorelin.
The approval history, and what “discontinued” actually means here
Sermorelin acetate was FDA-approved twice, both times under the brand name Geref, both times to the same manufacturer, EMD Serono. The first approval was in December 1990, for an injectable ampule formulation. The second came in September 1997, for higher-strength vials, and carried an orphan-drug designation [1]. Both approvals still exist in FDA’s records — but both products are now listed with a marketing status of Discontinued [1].
Here is the detail that actually matters, and it is a genuinely reassuring one, not a red flag: both discontinued Geref records carry FDA’s specific determination that the product was “not discontinued or withdrawn for safety or effectiveness reasons” [1]. In plain terms, Geref did not get pulled because it turned out to be dangerous or because it stopped working. It was discontinued for commercial reasons — the kind of business decision that ends a lot of older, lower-volume drug products. That determination is also the specific regulatory fact that keeps sermorelin acetate eligible to be used as an ingredient in compounded preparations today. A withdrawal for safety or efficacy reasons would generally have closed that door.
What “compounded” means, and why it is not the same as approved
Once Geref was discontinued, no company continued to hold an FDA-approved, finished sermorelin product on the market. What exists instead is sermorelin acetate as a bulk compounding ingredient — raw powder, sold to compounding pharmacies and outsourcing facilities, which then prepare it into an injectable product themselves. Checking FDA’s current drug listing records directly confirms this is the entire current market. Every active sermorelin acetate listing found is categorized as bulk ingredient for prescription compounding, not as an approved finished drug product [2].
This distinction is the whole regulatory story in one sentence: FDA approval is a determination about a specific, finished, manufactured product. That means the exact formulation, the exact manufacturing process, and the exact dose — not a chemical in the abstract. When a pharmacy compounds sermorelin from bulk powder, that compounded product has never itself gone through FDA’s approval process, no matter how well-established the underlying chemical’s history is. That is true of every compounded drug, not something specific to sermorelin.
One detail worth being precise about: FDA does track certain bulk substances used in outsourcing-facility compounding under section 503B of the FD&C Act. It sorts nominated substances into evaluation categories. Checking FDA’s current 503B bulk drug substances list directly, sermorelin acetate appears in Category 1 — “Bulk Drug Substances Under Evaluation”. It is specifically flagged there as a substance that is a component of an FDA-approved drug (the historical Geref approval) [3]. “Under evaluation” is exactly what it sounds like: FDA has not finished a formal determination on it either way. It is not a form of approval.
Is sermorelin legal?
Yes, generally — with the same major caveat that applies to any compounded prescription drug. Legality depends on getting it through a licensed prescriber and a properly licensed compounding pharmacy or outsourcing facility, not on buying raw peptide from an unregulated online seller with no prescription involved. “Legal” and “FDA-approved” are two different questions:
- FDA-approved means a specific, finished product went through FDA’s formal review process and was cleared for a specific use. Sermorelin currently has no approved product on the market — its two approvals are both historical and discontinued [1].
- Legal means the sale, prescription, and use of the substance is permitted under federal and state law, given the right pathway. Compounded sermorelin is prescribed by a licensed provider and prepared by a licensed pharmacy. It is generally legal, the same way any other legitimately compounded prescription drug is.
So: it is accurate to say sermorelin is legal to obtain through a legitimate prescription-and-compounding pathway. It is not accurate to say it is FDA-approved. It is especially not accurate to describe a compounded product as “FDA-approved compounded sermorelin” — that phrase mixes two things that do not belong in the same sentence.
Is sermorelin a controlled substance?
No. Checking the DEA’s current federal controlled-substances list directly — the same alphabetical schedule that would list any substance regulated under the Controlled Substances Act — sermorelin does not appear on it [4]. That puts it in a different legal category than anabolic steroids, which are explicitly scheduled. See what is sermorelin, and is it a steroid for that distinction in full. Not being a scheduled controlled substance does not mean sermorelin is unregulated, though — it is still a prescription drug.
What this means when you are evaluating a seller
There is no approved finished product to point to. So the usual “is this brand FDA-approved” shortcut does not apply to sermorelin the way it would with a conventional prescription drug. That makes the questions worth asking different, not fewer. A legitimate compounded-sermorelin pathway should involve an actual prescriber evaluating you, not just a form that auto-approves everyone. It should also involve a pharmacy or outsourcing facility that is licensed and inspectable. Those two things — a real prescriber and a licensed, accountable pharmacy — are what stand in for “FDA-approved” in a compounded-drug world. See the telehealth prescribers we could verify for sellers that actually run a prescriber-led intake, and what dose the trials actually used before taking a seller's dosing chart on faith.
The bottom line
Sermorelin was FDA-approved, under the name Geref, from 1990 until it was discontinued for commercial — not safety — reasons [1]. What is sold today is compounded from bulk sermorelin acetate. That is a legal and established pathway — but it is not, and cannot correctly be called, FDA approval [2]. FDA currently lists sermorelin acetate as a 503B bulk substance “under evaluation,” which is an open question, not a form of clearance [3]. And sermorelin is not a scheduled controlled substance under current federal law [4]. The single most useful thing to take away: legal and approved are not the same claim. Anyone selling you compounded sermorelin as “FDA-approved” is telling you something that is not true. For what the trials measured rather than what regulators say, see does sermorelin work.